HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
J Lacroix Selected Research
J Lacroix Research Topics
Disease
3
Multiple Organ Failure (MODS)
05/2013 - 06/2001
3
Neoplasms (Cancer)
06/2001 - 08/2000
2
Thromboembolism
02/2019 - 09/2012
2
Neoplasm Metastasis (Metastasis)
11/2015 - 12/2014
2
Critical Illness (Critically Ill)
05/2013 - 10/2000
2
Septic Shock (Toxic Shock Syndrome)
01/2003 - 01/2000
2
Death (Near-Death Experience)
10/2000 - 10/2000
1
Fatigue
09/2021
1
Head and Neck Neoplasms (Head and Neck Cancer)
12/2020
1
Brain Neoplasms (Brain Tumor)
12/2019
1
Hemorrhage
02/2019
1
Hypotension (Low Blood Pressure)
02/2016
1
Transfusion Reaction
02/2016
1
Cross Infection (Nosocomial Infection)
05/2013
1
Infections
10/2012
1
Surgical Wound
10/2012
1
Postoperative Hemorrhage
09/2012
1
Traumatic Brain Injuries (Traumatic Brain Injury)
01/2006
1
Hypothermia
01/2006
1
Back Pain (Backache)
10/2004
1
Radiculopathy (Radiculopathy, Cervical)
10/2004
1
Fistula
01/2004
1
Hypovolemia
01/2003
1
Shock
01/2003
1
Pancreatic Neoplasms (Pancreatic Cancer)
11/2001
1
Margins of Excision
06/2001
1
Sepsis (Septicemia)
06/2001
1
Systemic Inflammatory Response Syndrome (Sepsis Syndrome)
06/2001
1
Lung Neoplasms (Lung Cancer)
04/2001
1
Cerebral Palsy (Spastic Diplegia)
02/2001
1
Lung Injury
11/2000
1
Mammary Paget's Disease
11/2000
1
Pulmonary Edema
11/2000
1
Pancytopenia
09/2000
1
Transitional Cell Carcinoma
08/2000
1
Residual Neoplasm
08/2000
1
Neuroblastoma
02/2000
1
Thyroid Diseases (Thyroid Disease)
01/2000
1
Thyroid Neoplasms (Thyroid Cancer)
01/2000
Drug/Important Bio-Agent (IBA)
3
RNA-Directed DNA Polymerase (Reverse Transcriptase)
IBA
06/2001 - 01/2000
2
Anticoagulants
IBA
02/2019 - 09/2012
2
Bevacizumab (Avastin)
FDA Link
11/2015 - 12/2014
2
Hemoglobins (Hemoglobin)
IBA
10/2001 - 09/2000
2
Keratin-20 (Cytokeratin 20)
IBA
08/2000 - 01/2000
1
Indicators and Reagents (Reagents)
IBA
09/2021
1
Bradykinin
IBA
02/2016
1
Anti-Infective Agents (Microbicides)
IBA
10/2012
1
Amoxicillin-Potassium Clavulanate Combination (Co-amoxiclav)
FDA Link
10/2012
1
Anti-Bacterial Agents (Antibiotics)
IBA
10/2012
1
Rivaroxaban
IBA
09/2012
1
Antithrombins
IBA
09/2012
1
Tranexamic Acid (AMCA)
FDA Link
09/2012
1
Steroids
IBA
10/2004
1
Opioid Peptides (Opioid Peptide)
IBA
01/2003
1
Opiate Alkaloids
IBA
01/2003
1
Naloxone (Narcan)
FDA Link
Generic
01/2003
1
Estrogens (Estrogen)
FDA Link
11/2001
1
DNA (Deoxyribonucleic Acid)
IBA
06/2001
1
Cytokines
IBA
06/2001
1
Gastrins
IBA
04/2001
1
Synaptophysin
IBA
04/2001
1
Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)
IBA
04/2001
1
gastrin-releasing peptide precursor
IBA
04/2001
1
Cholecystokinin B Receptor
IBA
04/2001
1
Oxygen (Dioxygen)
IBA
02/2001
1
Hydrocarbons
IBA
11/2000
1
Pharmaceutical Preparations
IBA
02/2000
1
Protein Isoforms (Isoforms)
IBA
02/2000
1
Tubulin
IBA
02/2000
1
Cysteine (L-Cysteine)
FDA Link
02/2000
1
Serine (L-Serine)
FDA Link
02/2000
1
Lactic Acid (Lactate)
FDA Link
Generic
01/2000
1
Bicarbonates (Hydrogen Carbonate)
IBA
01/2000
1
Messenger RNA (mRNA)
IBA
01/2000
Therapy/Procedure
6
Therapeutics
10/2012 - 10/2000
4
Radiotherapy
12/2020 - 12/2014
2
Palliative Care (Palliative Therapy)
10/2000 - 10/2000
1
Hip Replacement Arthroplasty (Total Hip Replacement)
02/2019
1
Length of Stay
05/2013
1
Rewarming
01/2006
1
Gastrostomy
01/2004
1
Conservative Treatment
11/2000
1
Intravenous Injections
11/2000
1
Mastectomy (Mammectomy)
11/2000
1
Terminal Care (Care, Terminal)
10/2000